A molecular pore spans the double membrane of the coronavirus replication organelle

Georg Wolff,Ronald W. A. L. Limpens,Jessika C. Zevenhoven-Dobbe,Ulrike Laugks,Shawn Zheng,Anja W. M. de Jong,Roman I. Koning,David A. Agard,Kay Grünewald,Abraham J. Koster,Eric J. Snijder,Montserrat Bárcena
DOI: https://doi.org/10.1126/science.abd3629
IF: 56.9
2020-08-06
Science
Abstract:Coronavirus genome replication is associated with virus-induced cytosolic double-membrane vesicles, which may provide a tailored microenvironment for viral RNA synthesis in the infected cell. However, it is unclear how newly synthesized genomes and messenger RNAs can travel from these sealed replication compartments to the cytosol to ensure their translation and the assembly of progeny virions. In this study, we used cellular cryo–electron microscopy to visualize a molecular pore complex that spans both membranes of the double-membrane vesicle and would allow export of RNA to the cytosol. A hexameric assembly of a large viral transmembrane protein was found to form the core of the crown-shaped complex. This coronavirus-specific structure likely plays a key role in coronavirus replication and thus constitutes a potential drug target.
multidisciplinary sciences
What problem does this paper attempt to address?
The key problem that this paper attempts to solve is: **How does the coronavirus transport its newly synthesized genome and mRNA from the enclosed double - membrane vesicles (DMVs) to the cytoplasm to ensure that these RNAs can be translated and assembled into new virus particles?** Specifically, when the coronavirus infects host cells, it forms a complex virus - induced double - membrane vesicle (DMVs) in the cytoplasm, and these vesicles are the main sites for viral RNA replication. However, these DMVs are closed structures and should theoretically prevent the newly synthesized RNA inside them from directly entering the cytoplasm. Therefore, scientists are not clear how these newly synthesized RNAs escape from these closed vesicles and are finally translated into proteins or packaged into new virus particles. To solve this problem, the authors used cryo - electron microscopy (cryo - EM) technology to perform high - resolution imaging of cells infected with murine hepatitis virus (MHV, a β - coronavirus model). Through this method, they discovered a molecular pore complex spanning the double - layer membrane of DMV, and this pore complex may be the channel through which RNA is transported from DMVs to the cytoplasm. ### Main findings: 1. **Structure of the molecular pore complex**: This pore complex has six - fold symmetry, contains a platform about 24 nanometers wide embedded in the DMV membrane, and extends a coronet - like structure about 13 nanometers long into the cytoplasm. The opening of the pore on the inner side of the DMV cavity is narrow and gradually widens to the cytoplasmic side. 2. **Composition of the pore complex**: Researchers determined through subtomogram averaging that the core component of the pore complex is a hexamer composed of six nsp3 proteins. nsp3 is a large - molecular - weight non - structural protein containing multiple functional domains, some of which may be related to RNA binding. 3. **RNA transport mechanism**: Based on the above - mentioned structural features, researchers speculate that this pore complex may be the key channel used by the coronavirus to transport newly synthesized positive - strand RNA from DMVs to the cytoplasm, while the negative - strand template and double - stranded RNA intermediates may be retained inside DMVs. ### Significance: This study reveals a crucial but previously unknown step in the replication process of the coronavirus, that is, the mechanism of RNA export from the enclosed replication compartment. In addition, since this molecular pore complex seems to be a structure unique to the coronavirus, it may become a potential antiviral drug target. In conclusion, this paper solves the problem of coronavirus RNA export from the enclosed replication compartment and proposes a new direction for drug development.